A Randomized, Open-Label Trial to Evaluate Switching to...

JAIDS Journal of Acquired Immune Deficiency Syndromes 2017 / 02 Vol. 74; Iss. 2

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
74
Language:
english
Journal:
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI:
10.1097/QAI.0000000000001193
Date:
February, 2017
File:
PDF, 476 KB
english, 2017
Conversion to is in progress
Conversion to is failed